4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-058095
Chief Development Officer sold 3,289 shares at an average $15.85 ($52,128)
- Chief Development Officer acquired 3,289 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…